NSYS

Nortech Systems Inc. 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2002, and the nine-month period ended on the same date. Nortech Systems Inc. is a contract manufacturer of wire harnesses, cables, electromechanical assemblies, and printed circuit boards for commercial and defense industries. The company operates facilities in Minnesota, Wisconsin, and a new facility in Monterrey, Mexico, which began production in July 2002. During the quarter, the company sold its Medical Management segment (discontinued operations) and completed the acquisition of Manufacturing Assembly Solutions of Monterrey, Inc. (MAS).

Key Financial Metrics

Note: Total Debt calculated as Current maturities of notes/capital lease ($868,243) plus Long-Term notes/capital lease ($8,606,779). Working Capital calculated as Current Assets ($22,893,975) minus Current Liabilities ($9,587,759).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 7.0% in Q3 and 10.0% for the nine-month period compared to the prior year, driven primarily by increased revenue from the existing customer base.
• Profitability: Net income from continuing operations increased 54.7% in Q3 and 47.9% for the nine-month period. Gross margins improved to 18.1% for the nine-month period due to improved productivity, partially offset by unfavorable product mix.
• Expense Management: Operating expenses increased slightly in Q3 ($1.48M vs $1.47M) but rose significantly for the nine-month period ($5.00M vs $4.41M) due to higher costs associated with revenue volume and consulting/benefit costs. Interest expense decreased significantly due to lower debt levels and favorable rates.
• Cash Flow: Operating cash flow turned strongly positive, providing $3.4 million for the nine months ended Sept 30, 2002, compared to a use of $63,623 in the prior year period.
• Balance Sheet: Goodwill increased significantly to $1.77 million (from $83k) due to the MAS acquisition. Total liabilities decreased slightly year-over-year.

Guidance, Outlook, and Risks

• Outlook: Management anticipates revenue levels in the fourth quarter of 2002 to be slightly higher than the third quarter. The 90-day order backlog was approximately $9.88 million as of September 30, 2002, up from $9.22 million at the start of the quarter.
• Liquidity: Working capital increased to $13.3 million. Management believes operating cash flow and available credit facilities are sufficient to fund expected near-term growth.
• Acquisition Details: The acquisition of MAS was funded with $650,000 cash and a $1.2 million promissory note (6% interest). The note allows for repayment via stock issuance if the share price exceeds $7.00; otherwise, the company must repurchase shares at $7.00.
• Risks: Key risks include marketplace volatility affecting supply/demand, increased competition, reliability of operating facilities, labor availability, and general economic conditions. The company also notes risks related to the estimation of goodwill impairment and inventory reserves.

Investor Verification Checklist

• Debt Covenants & Repayment: Verify the terms of the $1.2 million promissory note for the MAS acquisition, specifically the conditions for stock issuance vs. cash repayment and the collateral assignment of 126,815 shares.
• Goodwill Valuation: Review the $1.27 million goodwill assigned to the MAS acquisition and the company's methodology for future impairment testing under SFAS 142.
• Inventory Levels: Monitor inventory balances, which totaled $12.57 million, against the company's stated reserves for excess or lower-value inventory.
• Discontinued Operations: Confirm the final financial impact of the sale of the Medical Management segment and ensure no lingering liabilities exist.
• Backlog Conversion: Track the conversion of the $9.88 million backlog into actual revenue in Q4 to validate management's guidance of slightly higher revenue.